← FDA DRUG APPROVALS

FDA ANDA · ANDA060111

STREPTOMYCIN SULFATE

Sponsor: PFIZER

APPLICATION
ANDA060111
TYPE
ANDA
ORIGINAL APPROVAL
1952-02-12
LATEST ACTION
1995-01-09
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

STREPTOMYCIN SULFATEDiscontinued
STREPTOMYCIN SULFATE EQ 1GM BASE/2.5ML · INJECTABLE · INJECTION

Approval history

1995-01-09Manufacturing (CMC) · Supplement 4AP
1993-07-08Labeling · Supplement 3AP
1993-04-23Labeling · Supplement 2AP
1993-04-23Manufacturing (CMC) · Supplement 1AP
1952-02-12OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →